Investing

Axovant, Genocea Plunge into Tuesday's 52-Week Low Club

September 26, 2017: Here are four stocks trading with heavy volume among 43 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by less than 3 to 2 and on the Nasdaq advancers led decliners by more than 4 to 3.

Axovant Sciences Ltd. (NASDAQ: AXON) dropped about 75% Tuesday to post a new 52-week low of $6.13 after closing at $24.25 on Monday. The stock’s 52-week high is $27.98. Volume of around 34 million was nearly 50 times the daily average. The company’s late stage trial of an Alzheimer disease treatment failed to meet its primary goals. Axovant joins a long list of companies that have failed to come up with a treatment for Alzheimer.

Genocea Biosciences Inc. (NASDAQ: GNCA) posted a new 52-week low of $1.30 on Tuesday, down about 76% from Monday’s closing price of $5.33. The stock’s 52-week high is $7.29. Volume totaled around 8.2 million shares, nearly 20 times the daily average. The company said today it was cutting staff and shifting its development focus.

Uniti Group Inc. (NASDAQ: UNIT) dropped about 10% Tuesday to post a new 52-week low of $15.61 after closing at $17.36 on Monday. The 52-week high is $32.62. Volume was around 9.3 million, more than 4 times the daily average. The company had no specific news Tuesday.

Windstream Holdings Inc. (NASDAQ: WIN) also dropped about 10% Tuesday to post a new 52-week low of $1.76 after closing Monday at $1.96. The 52-week high is $10.46. Volume of around 6.8 million shares traded was about 30% higher than the daily average. The company had no specific news.

Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE

Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.